CD44 and hepatocellular carcinoma: NEU4, a sialidase that removes sialic acids from glycoconjugates, has been shown to reduce the motility of hepatocellular carcinoma cells by cleaving sialic acids on CD44, thereby enhancing cell adhesion to the extracellular matrix68.